Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kimia Drug Sina is an Iranian pharmaceutical company focused on the manufacturing and distribution of a wide range of finished dosage forms. The company specializes in the production of essential medicines across various therapeutic categories, including antibiotics, cardiovascular drugs, analgesics, and gastrointestinal treatments. Operating with a focus on the domestic Middle Eastern market, Kimia Drug Sina provides both generic and branded generic medications in forms such as tablets, capsules, and oral suspensions. The company maintains modern manufacturing facilities designed to meet national health standards and ensure the availability of affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kimia Drug Sina.